🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and cyclop...
Status
Terminated
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2008-06-23
Trial ID
NCT00489281
The purpose of this study is to measure the effectiveness of 2 drugs, tacro...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2005-08
Trial ID
NCT00133367
Treatments Being Tested
To determine if rituximab administered after allogeneic transplantation dec...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2005-06
Trial ID
NCT00186628
The main purpose of this study is to find out whether treatment to prevent k...
Status
Completed
Location
Columbia University Medical Center
Start Date
2014-06
Trial ID
NCT02152345
Treatments Being Tested
An open-label randomized multicenter clinical study comparing three regimes...
Status
Completed
Location
Hopital Pellegrin Tripode
Start Date
2005-05
Trial ID
NCT00538265
Treatments Being Tested
Randomized study of autologous un-manipulated peripheral blood hematopoieti...
Status
Terminated
Location
Northwestern University
Start Date
2017-11-08
Trial ID
NCT03342638
Treatments Being Tested
Antithymocyte globulin (e.g., Thymoglobulin®) is an antibody preparation th...
Status
Terminated
Location
Children's Hospital/USC School of Medicine
Start Date
2007-08
Trial ID
NCT00515099
Treatments Being Tested
Patients who undergo a kidney transplant require prolonged therapy with dru...
Status
Completed
Location
California Institute Of Renal Research
Start Date
2015-12-31
Trial ID
NCT02137239
The purpose of this study is to evaluate the efficacy and side effects of d...
Status
Unknown
Location
Hematology-Oncology & SCT Research Center
Start Date
2009-09
Trial ID
NCT01087398
This phase II trial studies the side effects and best dose of bortezomib wh...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2007-02-13
Trial ID
NCT00439556